Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/ddg.15039_g | DOI Listing |
Eur J Endocrinol
January 2025
Bon Secours Hospital, UCC School of Medicine, Cork, Ireland.
Eur J Endocrinol
October 2024
Endocrinology Department, Hospital CUF Descobertas, 1998-018 Lisbon, Portugal.
The European Society of Endocrinology (ESE) and the Union Européenne des Médecins Spécialistes (U.E.M.
View Article and Find Full Text PDFHormones (Athens)
June 2024
Division of Endocrinology, Department of Internal Medicine, School of Medicine, Koç University, Istanbul, Turkey.
EndoBridge 2023 took place on October 20-22, 2023, in Antalya, Turkey. Accredited by the European Council, the 3-day scientific program of the 11 Annual Meeting of EndoBridge included state-of-the-art lectures and interactive small group discussion sessions incorporating interesting and challenging clinical cases led by globally recognized leaders in the field and was well attended by a highly diverse audience. Following its established format over the years, the program provided a comprehensive update across all aspects of endocrinology and metabolism, including topics in pituitary, thyroid, bone, and adrenal disorders, neuroendocrine tumors, diabetes mellitus, obesity, nutrition, and lipid disorders.
View Article and Find Full Text PDFPituitary
February 2024
Cedars-Sinai Medical Center, 8700 Beverly Blvd, NT 2015, Los Angeles, CA, 90048, USA.
Purpose: The 14th Acromegaly Consensus Conference was convened to consider biochemical criteria for acromegaly diagnosis and evaluation of therapeutic efficacy.
Methods: Fifty-six acromegaly experts from 16 countries reviewed and discussed current evidence focused on biochemical assays; criteria for diagnosis and the role of imaging, pathology, and clinical assessments; consequences of diagnostic delay; criteria for remission and recommendations for follow up; and the value of assessment and monitoring in defining disease progression, selecting appropriate treatments, and maximizing patient outcomes.
Results: In a patient with typical acromegaly features, insulin-like growth factor (IGF)-I > 1.
Wien Klin Wochenschr
January 2023
Klinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Spitalgasse 23, 1090, Wien, Österreich.
Diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state (HHS) represent potentially life-threatening situations in adults. Therefore, rapid comprehensive diagnostic and therapeutic measures with close monitoring of vital and laboratory parameters are required. The treatment of DKA and HHS is essentially the same and replacement of the mostly substantial fluid deficit with several liters of a physiological crystalloid solution is the first and most important step.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!